DOI: 10.1128/JVI.01741-19
Article Information
PubMed
Published By
History
- Received October 9, 2019
- Accepted December 1, 2019
- Published online February 14, 2020.
Copyright & Usage
Copyright © 2020 American Society for Microbiology. All Rights Reserved.
Editors and / or Reviewers
- Stacey Schultz-Cherry, Editor, St. Jude Children's Research Hospital
Article Versions
- Accepted Manuscript version (December 04, 2019).
- You are viewing the most recent version of this article.
Author Information
- Fatima Amanata,b,
- James Duehra,b,
- Cheng Huangc,
- Slobodan Paesslerc,
- Gene S. Tand,e and
- Florian Krammerb
- aGraduate School of Biological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA
- bDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
- cDepartment of Pathology, University of Texas Medical Branch at Galveston, Galveston, Texas, USA
- dInfectious Diseases, The J. Craig Venter Institute, La Jolla, California, USA
- eDivision of Infectious Disease, Department of Medicine, University of California San Diego, La Jolla, California, USA
- Address correspondence to Florian Krammer, florian.krammer{at}mssm.edu.
Citation Amanat F, Duehr J, Huang C, Paessler S, Tan GS, Krammer F. 2020. Monoclonal antibodies with neutralizing activity and Fc-effector functions against the Machupo virus glycoprotein. J Virol 94:e01741-19. https://doi.org/10.1128/JVI.01741-19.
